Skip to main content

Advertisement

SpringerLink
Log in

Current concepts in the evaluation and management of WHO grade II gliomas

  • Topic Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Over the past two decades, the accumulated clinical and research experience has improved our understanding the biology of WHO grade II gliomas (G2G). While there have been relatively few randomized clinical trials in this population, those that exist and the experience from clinical reports have enhanced our understanding of how these tumors progressively increase in size, accumulate additional genetic mutations and ultimately transform into high-grade lesions. Our ability to reliably predict the time sequence of this transformation remains a challenge; however, recent findings have started to clarify selection criteria for adjuvant treatment. G2G remain a fatal disease for many patients. Continued investigation into the biology of these lesions will likely provide the information needed to select more appropriate therapy based on biological and genetic differences in these unique lesions. Some of this information will be derived from the study of high-grade lesions. However, experience has shown that much of the work on high-grade lesions is also applicable to low-grade lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Piepmeier J, Christopher S, Spencer D, Byrne T, Kim J, Knisely J, Lacy J, Tsukerman L, Makuch R (1996) Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38:872–879. doi:10.1097/00006123-199605000-00002

    Article  PubMed  CAS  Google Scholar 

  2. Piepmeier J (1987) Observations on the current treatment of low grade astrocytic tumors of the cerebral hemispheres. J Neurosurg 67:177–181

    Article  PubMed  CAS  Google Scholar 

  3. Rees J, Watt H, Jäger HR, Benton C, Tozer D, Tofts P, Waldman A (2008) Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol [Epub ahead of print]

  4. Chang E, Smith J, Chang S, Lamborn S, Prados M, Butowski N, Barbaro N, Parse A, Berger M, McDermott M (2008) Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg 109:817–824. doi:10.3171/JNS/2008/109/11/0817

    Article  PubMed  Google Scholar 

  5. Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, Wara W, MacDonald D, Stitt L, Cairncross JG (1999) Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45(4):923–929. doi:10.1016/S0360-3016(99)00284-9

    PubMed  CAS  Google Scholar 

  6. Trembath D, Miller CR, Perry A (2008) Gray zones in brain tumor classification: evolving concepts. Adv Anat Pathol 15(5):287–297. doi:10.1097/PAP.0b013e3181836a03

    Article  PubMed  Google Scholar 

  7. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26(8):1338–1345. doi:10.1200/JCO.2007.13.9337

    Article  PubMed  Google Scholar 

  8. Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F, Jolesz FA, Black PM (2005) Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103(6):1227–1233. doi:10.1002/cncr.20867

    Article  PubMed  Google Scholar 

  9. Robles SG, Gatignol P, Lehéricy S, Duffau H (2008) Long-term brain plasticity allowing a multistage surgical approach to World Health Organization Grade II gliomas in eloquent areas. J Neurosurg 109(4):615–624. doi:10.3171/JNS/2008/109/10/0615

    Article  PubMed  Google Scholar 

  10. Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62(4):753–764. doi:10.1227/01.neu.0000318159.21731.cf

    Article  PubMed  Google Scholar 

  11. Shaw EG, Berkey B, Coons SW, Bullard D, Brachman D, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta M (2008) Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. J Neurosurg 109(5):835–841. doi:10.3171/JNS/2008/109/11/0835

    Article  PubMed  Google Scholar 

  12. van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmström PO, Collette L, Piérart M, Mirimanoff R, Karim AB (2005) EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366(9490):985–990. doi:10.1016/S0140-6736(05)67070-5

    Article  PubMed  Google Scholar 

  13. Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M (1996) A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36(3):549–556. doi:10.1016/S0360-3016(96)00352-5

    PubMed  CAS  Google Scholar 

  14. Shaw EG, Tatter SB, Lesser GJ, Ellis TL, Stanton CA, Stieber VW (2004) Current controversies in the radiotherapeutic management of adult low-grade glioma. Semin Oncol 31(5):653–658. doi:10.1053/j.seminoncol.2004.07.007

    Article  PubMed  Google Scholar 

  15. Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, Hoang-Xuan K (2007) Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 68(21):1831–1836. doi:10.1212/01.wnl.0000262034.26310.a2

    Article  PubMed  CAS  Google Scholar 

  16. Sijens PE, Heesters MA, Enting RH, van der Graaf WT, Potze JH, Irwan R, Meiners LC, Oudkerk M (2007) Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy. Cancer Invest 25(8):706–710. doi:10.1080/07357900701564028

    Article  PubMed  CAS  Google Scholar 

  17. Idbaih A, Carvalho Silva R, Crinière E, Marie Y, Carpentier C, Boisselier B, Taillibert S, Rousseau A, Mokhtari K, Ducray F, Thillet J, Sanson M, Hoang-Xuan K, Delattre JY (2008) Genomic changes in progression of low-grade gliomas. J Neurooncol [Epub ahead of print]

  18. Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Brown PD, Shaw EG, Buckner JC (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66(20):9852–9861. doi:10.1158/0008-5472.CAN-06-1796

    Article  PubMed  CAS  Google Scholar 

  19. Ngo TT, Peng T, Liang XJ et al (2007) The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas. J Natl Cancer Inst 99:639–652. doi:10.1093/jnci/djk135

    Article  PubMed  CAS  Google Scholar 

  20. Liang XJ, Choi Y, Sackett DL, Park JK (2008) Nitrosoureas inhibit the stathmin-mediated migration and invasion of malignant glioma cells. Cancer Res 68(13):5267–5272. doi:10.1158/0008-5472.CAN-07-6482

    Article  PubMed  CAS  Google Scholar 

  21. Hegi ME, Liu L, Herman JG, Stupp R, Wick W, Weller M, Mehta MP, Gilbert MR (2008) Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26(25):4189–4199. doi:10.1200/JCO.2007.11.5964

    Article  PubMed  CAS  Google Scholar 

  22. Möllemann M, Wolter M, Felsberg J, Collins VP, Reifenberger G (2005) Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J Cancer 113(3):379–385. doi:10.1002/ijc.20575

    Article  PubMed  CAS  Google Scholar 

  23. Lavon I, Zrihan D, Zelikovitch B, Fellig Y, Fuchs D, Soffer D, Siegal T (2007) Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas. Clin Cancer Res 13(5):1429–1437. doi:10.1158/1078-0432.CCR-06-2050

    Article  PubMed  CAS  Google Scholar 

  24. Campbell B, Horsman D, Maguire J, Young S et al (2008) Chromosomal alterations in oligodendroglial tumours over multiple surgeries: is tumour progression associated with change in 1p/19q status? J Neurooncol 89:37–45. doi:10.1007/s11060-008-9597-2

    Article  PubMed  CAS  Google Scholar 

  25. Mainio A, Tuunanen S, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2006) Decreased quality of life and depression as predictors for shorter survival among patients with low grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci 256(8):516–521. doi:10.1007/s00406-006-0674-2

    Article  PubMed  Google Scholar 

  26. Correa DD, Shi W, Thaler HT, Cheung AM, DeAngelis LM, Abrey LE (2008) Longitudinal cognitive follow-up in low grade gliomas. J Neurooncol 86(3):321–327. doi:10.1007/s11060-007-9474-4

    Article  PubMed  Google Scholar 

  27. Brown R, Zlatescu M, Sijben A, Roldan G, Easaw J, Forsyth P, Parney I, Sevick R, Yan E, Demetrick D, Schiff D, Cairncross G, Mitchell R (2008) The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendroglioma. Clin Cancer Res 14(8):2357–2362. doi:10.1158/1078-0432.CCR-07-1964

    Article  PubMed  CAS  Google Scholar 

  28. Roelcke U, Wyss M, Bärtschi E, Hofer S (2007) Metabolic deactivation of low-grade glioma during chemotherapy. J Neurol 254(5):668–669. doi:10.1007/s00415-006-0321-x

    Article  PubMed  Google Scholar 

  29. Tozer DJ, Jäger HR, Danchaivijitr N, Benton CE, Tofts PS, Rees JH, Waldman AD (2007) Apparent diffusion coefficient histograms may predict low-grade glioma subtype. NMR Biomed 20(1):49–57. doi:10.1002/nbm.1091

    Article  PubMed  Google Scholar 

  30. Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, Rees JH, Jäger HR (2008) Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology 247(1):170–178

    Article  PubMed  Google Scholar 

  31. Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J, Kelly PJ (2006) Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery 58(6):1099–1107. doi:10.1227/01.NEU.0000215944.81730.18

    Article  PubMed  Google Scholar 

  32. Baehring J, Bi L, Bannyhk S, Piepmeier J, Fulbright R (2007) Diffusion MRI in the early diagnosis of malignant glioma. J Neurooncol 82(2):221–225. doi:10.1007/s11060-006-9273-3

    Article  PubMed  Google Scholar 

  33. Kato T, Shinoda J, Oka N, Miwa K, Nakayama N, Yano H, Maruyama T, Muragaki Y, Iwama T (2008) Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity. AJNR Am J Neuroradiol [Epub ahead of print]

  34. Gozé C, Rigau V, Gibert L, Maudelonde T, Duffau H (2009) Lack of complete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: a marker of worse prognosis? J Neurooncol 91(1):1–5. doi:10.1007/s11060-008-9680-8

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA

    Joseph M. Piepmeier

Authors
  1. Joseph M. Piepmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph M. Piepmeier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piepmeier, J.M. Current concepts in the evaluation and management of WHO grade II gliomas. J Neurooncol 92, 253–259 (2009). https://doi.org/10.1007/s11060-009-9870-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-009-9870-z

Keywords

Search

Navigation